Susquehanna International Group
ATHE

Susquehanna International Group’s Alterity Therapeutics ATHE Stock Holding History

Susquehanna International Group’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-267
Closed -$19K – 9605
2015
Q2 		$19K Sell
267
-385
-59% -$28.9K ﹤0.01% 10003
2015
Q1 		$44K Sell
652
-638
-49% -$50.9K ﹤0.01% 9173
2014
Q4 		$127K Sell
1,290
-1,667
-56% -$180K ﹤0.01% 9093
2014
Q3 		$380K Sell
2,957
-910
-24% -$122K ﹤0.01% 7678
2014
Q2 		$524K Sell
3,867
-3,813
-50% -$435K ﹤0.01% 7382
2014
Q1 		$1.29M Buy
7,680
+5,325
+226% +$2.94M ﹤0.01% 5066
2013
Q4 		$991K Buy
2,355
+1,568
+199% +$469K ﹤0.01% 5526
2013
Q3 		$194K Buy
+787
New +$181K ﹤0.01% 7795

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
TLCM
Twin Lakes Capital Management Redwood Shores, California $220M AUM 31.75% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Susquehanna International Group's ATHE Position: Q4 2024 in Review

Susquehanna International Group sold out of Alterity Therapeutics (ATHE) in Q4 2024, closing a stake of 13,932 shares — an estimated $18.7K sold.

Susquehanna International Group first reported a position in ATHE in Q3 2013 and held it in 17 quarters. The position peaked at $706K in Q1 2014. 13 funds tracked by Wall St. Rank hold ATHE as of Q4 2024.

  • Susquehanna International Group reported no remaining Alterity Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 13,932 Alterity Therapeutics shares in Q4 2024, an estimated $18.7K.
  • Susquehanna International Group first reported a position in Alterity Therapeutics in Q3 2013 and held it in 17 quarters.
  • Susquehanna International Group's Alterity Therapeutics position peaked at $706K in Q1 2014.
  • 13 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.